Virtu Financial’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-40,370
Closed -$1.02M 2432
2018
Q2
$1.02M Buy
40,370
+14,091
+54% +$348K 0.06% 385
2018
Q1
$646K Buy
26,279
+1,547
+6% +$39.7K 0.03% 564
2017
Q4
$632K Buy
+24,732
New +$628K 0.03% 679

Other funds holding LDRS

Virtu Financial's LDRS Position: Q3 2018 in Review

Virtu Financial sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q3 2018, closing a stake of 40,370 shares — an estimated $1.02M sold.

Virtu Financial first reported a position in LDRS in Q4 2017 and held it in 3 quarters. The position peaked at $1.02M in Q2 2018. 18 funds tracked by Wall St. Rank hold LDRS as of Q3 2018.

  • Virtu Financial reported no remaining Innovator IBD ETF Leaders ETF position as of Q3 2018 after selling out during the quarter.
  • Virtu Financial sold 40,370 Innovator IBD ETF Leaders ETF shares in Q3 2018, an estimated $1.02M.
  • Virtu Financial first reported a position in Innovator IBD ETF Leaders ETF in Q4 2017 and held it in 3 quarters.
  • Virtu Financial's Innovator IBD ETF Leaders ETF position peaked at $1.02M in Q2 2018.
  • 18 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q3 2018.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.